Get the app
Rachid Baz
Myeloma section head in the Department of Malignant Hematology at Moffitt Cancer Center. Focuses on bispecific antibody therapies and practical considerations for T-cell therapies.
Best podcasts with Rachid Baz
Ranked by the Snipd community
May 2, 2025
• 35min
Highlights from iwMyeloma 2025: trial updates and practical considerations
chevron_right
Join Damian Green, a leader in cellular immunotherapy at the University of Miami, and Rachid Baz, a myeloma specialist at Moffitt Cancer Center, as they dive into the latest breakthroughs in multiple myeloma treatments. They discuss the benefits and challenges of T-cell therapies, including managing side effects and improving access to treatment. There's also a focus on innovative therapies like bispecific antibodies, the importance of personalized medicine, and real patient stories that highlight transformative outcomes.
The AI-powered Podcast Player
Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
Get the app